Literature DB >> 9038797

Respiratory health of workers exposed to low levels of chromium in stainless steel production.

M Huvinen1, J Uitti, A Zitting, P Roto, K Virkola, P Kuikka, P Laippala, A Aitio.   

Abstract

OBJECTIVES: To determine whether occupational exposure to chromite, trivalent chromium, or hexavalent chromium causes respiratory diseases, an excess of respiratory symptoms, a decrease in pulmonary function, or signs of pneumoconiosis among workers in an integrated chain of stainless steel production.
METHODS: This cross sectional study was carried out in 1993 and the inclusion criterion was a minimum of eight years of employment in the same production department. A self administered questionnaire was collected, and spirometry, measurement of diffusing capacity, chest radiography, and laboratory tests were carried out by a mobile research unit.
RESULTS: There were 221 workers in the exposure groups and 95 in the control group. The average duration of employment was 18 years. No significant differences in the odds ratios (ORs) of the symptoms were found between the exposure and the control groups. In a logistic regression analysis age and smoking significantly explained the occurrence of most of the respiratory symptoms. The smokers in the chromite group had significantly lower forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and diffusing capacity than the corresponding values of the control group. The analysis of variance between study groups, smoking, and exposure time, without modelling for interactions, showed that the chromite group had lower values for FVC, FEV1, and diffusing capacity than the other groups. The occurrence of small opacities was more frequent on the chest radiographs of the workers in the chromite group.
CONCLUSIONS: An average exposure time of 18 years in ferrochromium and stainless steel production and exposure to dusts containing low concentrations of hexavalent or trivalent chromium do not lead to any respiratory changes detectable by lung function tests or radiography nor to any increase in symptoms of respiratory diseases. The lung function values were lower and the occurrence of radiological findings was more frequent among the workers from the chromite mine than among the controls. The difference was partly caused by differences in age and smoking habits, but evidently also partly by higher exposures more than two decades ago or by the fibrous components of the dust.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9038797      PMCID: PMC1128591          DOI: 10.1136/oem.53.11.741

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  11 in total

1.  Occupational cancer and other health hazards in a chromate plant: a medical appraisal. I. Lung cancers in chromate workers.

Authors:  T F MANCUSO; W C HUEPER
Journal:  Ind Med Surg       Date:  1951-08

2.  Acute pulmonary complications following inhalation of chromic acid mist; preliminary observations of 2 patients who inhaled massive amounts of chromic acid.

Authors:  J B MEYERS
Journal:  AMA Arch Ind Hyg Occup Med       Date:  1950-12

3.  Spirometric alterations in workers in the chromium electroplating industry.

Authors:  P Bovet; M Lob; M Grandjean
Journal:  Int Arch Occup Environ Health       Date:  1977-10-17       Impact factor: 3.015

4.  [Respiratory functional changes in subjects exposed to chromium. I. Spirographic changes].

Authors:  A Reggiani; M Lotti; E De Rosa; B Saia
Journal:  Lav Um       Date:  1973-01

5.  Chrome plating: symptoms, findings in the upper airways, and effects on lung function.

Authors:  E Lindberg; G Hedenstierna
Journal:  Arch Environ Health       Date:  1983 Nov-Dec

6.  Body plethysmographic studies in non-smoking, healthy adults.

Authors:  A A Viljanen; B C Viljanen; P K Halttunen; K E Kreus
Journal:  Scand J Clin Lab Invest Suppl       Date:  1982

Review 7.  Single breath diffusing capacity in the industrial setting.

Authors:  B Make; A Miller; G Epler; J B Gee
Journal:  Chest       Date:  1982-09       Impact factor: 9.410

8.  A survey of respiratory symptoms and lung function in ferrochromium and ferrosilicon workers.

Authors:  S Langård
Journal:  Int Arch Occup Environ Health       Date:  1980       Impact factor: 3.015

9.  Respiratory and allergic symptoms in wool textile workers.

Authors:  R G Love; T A Smith; D Gurr; C A Soutar; D A Scarisbrick; A Seaton
Journal:  Br J Ind Med       Date:  1988-11

10.  Mortality from lung cancer and cardiovascular diseases among stainless-steel producing workers.

Authors:  J J Moulin; P Wild; B Mantout; M Fournier-Betz; J M Mur; G Smagghe
Journal:  Cancer Causes Control       Date:  1993-03       Impact factor: 2.506

View more
  5 in total

1.  Respiratory health of dust-exposed Congolese coltan miners.

Authors:  Ngombe Leon-Kabamba; Nlandu Roger Ngatu; Sakatolo Jean-Baptiste Kakoma; Christophe Nyembo; Etongola Papy Mbelambela; Reiko Juliana Moribe; Stanislas Wembonyama; Brigitta Danuser; Numbi Oscar-Luboya
Journal:  Int Arch Occup Environ Health       Date:  2018-06-27       Impact factor: 3.015

Review 2.  Toxicity and oxidative stress induced by chromium in workers exposed from different occupational settings around the globe: A review.

Authors:  Muhammad Junaid; Muhammad Zaffar Hashmi; Riffat Naseem Malik; De-Sheng Pei
Journal:  Environ Sci Pollut Res Int       Date:  2016-08-25       Impact factor: 4.223

3.  Cancer incidence among Finnish ferrochromium and stainless steel production workers in 1967-2011: a cohort study.

Authors:  Markku Huvinen; Eero Pukkala
Journal:  BMJ Open       Date:  2013-11-19       Impact factor: 2.692

Review 4.  Biopersistent granular dust and chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Irene Brüske; Elisabeth Thiering; Joachim Heinrich; Katharina Huster; Dennis Nowak
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

5.  Cause-specific mortality in Finnish ferrochromium and stainless steel production workers.

Authors:  M Huvinen; E Pukkala
Journal:  Occup Med (Lond)       Date:  2015-12-08       Impact factor: 1.611

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.